Corteria Pharmaceuticals

SECTOR : Biotech
ENTRY DATE : 2021
BUSINESS : Venture Capital
WEB : www.corteriapharma.com/


Corteria Pharmaceuticals

Advancing therapies for cardiovascular disease

Corteria Pharmaceuticals is a French biotechnology company specialized in the development of interceptive therapies for heart failure sub-populations.


PRESS RELEASE(S) :

09/12/2021 Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets

Read

 

Search